Table 1.

Demographics and clinical characteristics of patients 1–4 with IPF

CharacteristicPatient 1Patient 2Patient 3Patient 4
Sex 
Age at diagnosis (yr) 32 57 72 52 
FVC (% predicted) 89 78 102 62 
DLCOc (% predicted) 40 65 75 47 
Smoking behavior Former Former Former Never 
Pack years 27 30 NA 
HRCT pattern Probable UIP Probable UIP Probable UIP Probable UIP 
Inspiratory crackles Yes Yes No Yes 
Digital clubbing No Yes No No 
Additional STS Liver disease Peritoneal fibrosis Liver disease; thrombocytopenia, RBC macrocytosis No 
T/Sobs-exp −0.488 −0.301 −0.236 −0.204 
T/S <10th percentile Yes Yes Yes Yes 
CharacteristicPatient 1Patient 2Patient 3Patient 4
Sex 
Age at diagnosis (yr) 32 57 72 52 
FVC (% predicted) 89 78 102 62 
DLCOc (% predicted) 40 65 75 47 
Smoking behavior Former Former Former Never 
Pack years 27 30 NA 
HRCT pattern Probable UIP Probable UIP Probable UIP Probable UIP 
Inspiratory crackles Yes Yes No Yes 
Digital clubbing No Yes No No 
Additional STS Liver disease Peritoneal fibrosis Liver disease; thrombocytopenia, RBC macrocytosis No 
T/Sobs-exp −0.488 −0.301 −0.236 −0.204 
T/S <10th percentile Yes Yes Yes Yes 

DLCOc, diffusing capacity of the lungs for carbon monoxide corrected for hemoglobin concentration; FVC, forced vital capacity; STS, short telomere syndrome; T/Sobs-exp, telomere length adjusted for age calculated by the difference between observed T/S ratio and the age-adjusted normal value.

or Create an Account

Close Modal
Close Modal